First Trust NYSE Arca Biotechnology Index Fund
250 hedge funds and large institutions have $535M invested in First Trust NYSE Arca Biotechnology Index Fund in 2024 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 57 increasing their positions, 88 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
250
Holders Change
+8
Holders Change %
+3.31%
% of All Funds
3.64%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
34
Increased
57
Reduced
88
Closed
24
Calls
$2.94M
Puts
–
Net Calls
+$2.94M
Net Calls Change
+$634K
Top Buyers
| 1 |
Jane Street
New York
|
+$6.26M |
| 2 |
CAG
Csenge Advisory Group
Clearwater,
Florida
|
+$4.11M |
| 3 |
NA
Navellier & Associates
Reno,
Nevada
|
+$3.28M |
| 4 |
GWA
GGM Wealth Advisors
Baltimore,
Maryland
|
+$3.17M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$2.49M |
Top Sellers
| 1 |
Wells Fargo
San Francisco,
California
|
-$8.83M |
| 2 |
LPL Financial
San Diego,
California
|
-$7.9M |
| 3 |
Morgan Stanley
New York
|
-$7.68M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4.96M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$4.78M |